In an essay in the September/October 2010 issue of Annals of Family Medicine, Leif Hass, MD, of Alta Bates Summit Medical Center in Oakland, Calif. reflects on how his own drug-resistant staphylococcus infection affected his work in the hospital. Writing in "Losing Touch: Do Physicians Lose Connectedness with Patients When They Wear Exam Gloves? One Physician's Personal Reflection," Hass discusses how his subsequent decision to wear gloves during patient encounters created a barrier, not only to infection, but also between himself and his patients. He reflects on the value of touch as a communication tool in the doctor-patient relationship, especially as means of bridging large socioeconomic and cultural gaps. He concludes the implications of contact precautions must be considered as healthcare providers reflect on balancing patient-centered care with infection prevention and control.
Hass writes, "I understand objectively that I do not need to wear gloves with all my patients, but for a great number of patients, all clinicians must take considerable precautions to prevent the spread of infection. Guidelines support the use of alcohol-based foam products rather than gloves except when multidrug-resistant pathogens are confirmed, but given the increasing rates and virulence of these organisms, I am not convinced such measures will continue to be enough to protect our patients. I know, however, another important reason I now wear gloves is out of fear for my family and me. Yet I see touch as a communication tool. For me, touch is particularly important when trying to bridge large socioeconomic and cultural gaps. A hand on the shoulder or the knee or a thoughtful physical examination, I believe, can make a patient understand at a deep nonverbal level you are there for them. I work hard to demonstrate concern for my patients with tone of voice, facial expressions, and body language, yet I feel I am losing some connectedness without skin-to-skin contact."
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.